688075 安旭生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.2011.3393.7292.68875.847
总资产报酬率 ROA (%)-0.1811.2133.3272.22259.516
投入资产回报率 ROIC (%)-0.1911.2953.5732.52970.577

边际利润分析
销售毛利率 (%)40.80042.50439.10242.29874.782
营业利润率 (%)-19.89715.41738.39233.27357.232
息税前利润/营业总收入 (%)34.23129.33431.85914.47948.426
净利润/营业总收入 (%)-14.54315.33735.55328.00549.371

收益指标分析
经营活动净收益/利润总额(%)351.098-106.65518.31542.170119.289
价值变动净收益/利润总额(%)-220.195206.72586.23259.3151.392
营业外收支净额/利润总额(%)-0.1717.0811.451-16.457-0.265

偿债能力分析
流动比率 (X)8.87310.50410.0358.7884.569
速动比率 (X)8.61210.1999.7268.4284.424
资产负债率 (%)10.6229.0909.87211.81122.044
带息债务/全部投入资本 (%)4.6621.7981.5772.4893.782
股东权益/带息债务 (%)2,012.9405,380.7056,128.4533,815.5472,465.186
股东权益/负债合计 (%)842.1371,000.923913.676747.187353.842
利息保障倍数 (X)0.6332.302-4.489-1.027-5.596

营运能力分析
应收账款周转天数 (天)236.785155.867133.025155.98222.029
存货周转天数 (天)290.061194.609188.213244.44251.010